Andreas Liebl

Evaluation of risk factors for development of complications in Type II diabetes in Europe

Andreas Liebl, É. Eschwège · Diabetologia · 2002 · 217 citations · Full text

Obesity, Metabolic Syndrome, Disease Risk Assessment +11

[Costs of type 2 diabetes in Germany. Results of the CODE-2 study].

Andreas Liebl, A Neiss, A Spannheimer et al. · PubMed · 2001 · 68 citations

Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*

Stephen C. Jones, Marian Benroubi, Conxa Castell et al. · Current Medical Research and Opinion · 2009 · 46 citations

A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes

Joseph M. Tibaldi, Martin Hadley‐Brown, Andreas Liebl et al. · Diabetes Obesity and Metabolism · 2018 · 46 citations · Full text

Clinical Outcomes After Insulin Initiation in Patients with Type 2 Diabetes: 24-Month Results from INSTIGATE

Andreas Liebl, Steven M. Jones, Albert Goday et al. · Diabetes Therapy · 2012 · 15 citations · Full text